210 related articles for article (PubMed ID: 35943518)
1. Clinical and imaging predictors of the natural course of bland portal vein thrombus in cirrhotic patients.
Konanur M; Reynolds C; Shropshire E; Lerebours R; Wildman-Tobriner B; Allen B; Jaffe T; Erkanli A; Bashir M
Abdom Radiol (NY); 2022 Nov; 47(11):3724-3732. PubMed ID: 35943518
[TBL] [Abstract][Full Text] [Related]
2. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.
Qi X; Han G; He C; Yin Z; Zhang H; Wang J; Xia J; Cai H; Yang Z; Bai M; Wu K; Fan D
Med Sci Monit; 2012 Aug; 18(8):HY37-41. PubMed ID: 22847208
[TBL] [Abstract][Full Text] [Related]
4. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
[TBL] [Abstract][Full Text] [Related]
5. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
[TBL] [Abstract][Full Text] [Related]
6. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.
Merola J; Fortune BE; Deng Y; Ciarleglio M; Amirbekian S; Chaudhary N; Shanbhogue A; Ayyagari R; Rodriguez-Davalos MI; Teperman L; Charles HW; Sigal SH
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):668-675. PubMed ID: 29462027
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
[TBL] [Abstract][Full Text] [Related]
9. Large Bore Portal Vein Thrombectomy: An Inari FlowTriever Case Series.
Sullivan IW; Fonseca A; Brown M; Ness J; Borge M; Amin P; Molvar C
Cardiovasc Intervent Radiol; 2023 Jan; 46(1):136-141. PubMed ID: 36261506
[TBL] [Abstract][Full Text] [Related]
10. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.
Thornburg B; Desai K; Hickey R; Hohlastos E; Kulik L; Ganger D; Baker T; Abecassis M; Caicedo JC; Ladner D; Fryer J; Riaz A; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2017 Dec; 28(12):1714-1721.e2. PubMed ID: 29050854
[TBL] [Abstract][Full Text] [Related]
11. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaiting liver transplantation: A case report.
Wang J; Chai JS; Zhang YM
Medicine (Baltimore); 2018 Jun; 97(26):e11183. PubMed ID: 29952969
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients.
Sandrasegaran K; Tahir B; Nutakki K; Akisik FM; Bodanapally U; Tann M; Chalasani N
AJR Am J Roentgenol; 2013 Dec; 201(6):1211-9. PubMed ID: 24261359
[TBL] [Abstract][Full Text] [Related]
14. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
[TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
[TBL] [Abstract][Full Text] [Related]
16. Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features.
Jha RC; Khera SS; Kalaria AD
AJR Am J Roentgenol; 2018 Jul; 211(1):14-24. PubMed ID: 29792748
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
[TBL] [Abstract][Full Text] [Related]
19. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
